Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
22,942,535
-
Share change
-
+2,252,505
-
Total reported value
-
$3,028,697,628
-
Put/Call ratio
-
103%
-
Price per share
-
$132.01
-
Number of holders
-
199
-
Value change
-
+$317,198,916
-
Number of buys
-
94
-
Number of sells
-
82
Institutional Holders of GW PHARMACEUTICALS PLC - ADS (GWPH) as of Q4 2017
As of 31 Dec 2017,
GW PHARMACEUTICALS PLC - ADS (GWPH) was held by
199 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,942,535 shares.
The largest 10 holders included
SCOPIA CAPITAL MANAGEMENT LP, Capital Research Global Investors, PRUDENTIAL PLC, Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, BlackRock Inc., CITADEL ADVISORS LLC, FMR LLC, and Consonance Capital Management LP.
This page lists
199
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.